Skip to main content
Menu
US

CP 55940, [Side Chain-2,3,4-3H(N)]-, 250µCi (9.25MBq)

CP 55,940, tritiated on the side chain-2,3-4 position. CP 55,940 is a synthetic cannabinoid that acts as a full agonist at both cannabinoid CB1 and CB2 receptors, and can also upregulate serotonin 5-HT2A receptors.

For research use only. Not for use in diagnostic procedures.

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Feature Specification
Concentration 1 mCi/ml
Label Position Nominally Labeled
Molecular Weight 376
Receptor Cannabinoid

CP 55,940, tritiated on the side chain-2,3-4 position. CP 55,940 is a synthetic cannabinoid that acts as a full agonist at both cannabinoid CB1 and CB2 receptors, and can also upregulate serotonin 5-HT2A receptors.

For research use only. Not for use in diagnostic procedures.

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Product Variants
Unit Size: 25 µCi
Part #:
NET1051025UC
List Price
USD 1,353.00
Unit Size: 250 µCi
Part #:
NET1051250UC
List Price
USD 3,752.00
Unit Size: 1 mCi
Part #:
NET1051001MC
List Price
USD 10,340.00

Overview

250 µCi quantity of CP 55940, [Side Chain-2,3,4-3H(N)]-, is available for your research.

CP 55,940 is a synthetic cannabinoid that mimics the effects of naturally occuring tetrahydrocannabinol (THC). It acts as a full agonist at cannabinoid receptors type 1 and 2. These GPCRs are potential drug targets for a variety of diseases, including epilepsy, cancer, obesity, and osteoporosis.

We offer both agonist and antagonist radioligands for autoradiographic visualization or performing saturation and competition assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radioligands is fully characterized for pharmacological action and validated in receptor binding assays.

Radiolabeled ligands remain the most sensitive method for probing receptor binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.

References for NET1051:

  1. Chiang, Y.-C. and Chen, J.-C. (2007), The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats. Journal of Neurochemistry, 103: 2505–2517.
  2. Gatch MB, Kozlenkov A, Huang RQ, Yang W, Nguyen JD, González-Maeso J, et al. (2013), The HIV antiretroviral drug efavirenz has LSD-like properties. Neuropsychopharmacology, 38: 2373–2384.

Specifications

Concentration
1 mCi/ml
Molecular Weight
376
Application
Drug Discovery & Development
Brand
NEN Radiochemicals
Buffer/Solvent
Ethanol
Detection Modality
Radiometric
Label Position
Nominally Labeled
Packaging
NENSure vial
Radioisotope
3H
Receptor
Cannabinoid
Shipping Conditions
Shipped in Dry Ice
Special Ordering Information
This is a radioactive product - shipping address must have a license to receive radioactive materials.
Storage Conditions
-20°C
Therapeutic Area
Angiogenesis
Cardiovascular
CNS & Neurologic
Gastrointestinal
Inflammation
Metabolic Disorders
Pain
Unit Size
250 µCi

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Product Info Icon
Product Info
Calendar: NEN® Radiochemicals 2024 Fresh Lot
Flyer Icon
Flyer
NENSure: The safest packaging for radiochemicals
Scroll Icon